Award
National Cancer Institute 5R01CA258602-05
Cancer Resistant Mice
Recipient
National Cancer Institute (NCI)
Award Amount
$680,577.00
Ceiling
$680,577.00
Awarded
December 12, 2025
Identifier
5R01CA258602-05
Research project funded by the National Cancer Institute to study cancer resistance in mice, aiming to identify mutations that could inform human cancer therapy. Total budget approximately $680,577 for FY 2026.
Description
This is a research project focused on cancer resistance in mice, with potential translational applications in human cancer therapy. The project involves genetic screening, mutagenesis, and mechanistic studies. The project aims to identify mutations conferring resistance to transplantable cancers and to explore their potential in human therapy.